Melissa Starovasnik
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Melissa A. Starovasnik is an Independent Director at Twist Bioscience Corp.
since 2021.
Formerly, Dr. Starovasnik was Vice President-Protein Sciences at Genentech, Inc. from 2011 to 2017.
Dr. Starovasnik completed an undergraduate degree in 1987 and a doctorate in 1992, both at the University of Washington.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TWIST BIOSCIENCE CORP. 0,04 % | 28/05/2026 | 22.222 ( 0,04 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Director/Miembro de la Junta | 06/08/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Twist Bioscience Corp.
Twist Bioscience Corp. BiotechnologyHealth Technology Manufactures, distributes and sells synthetic DNA products through online | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.